It means a recommendation backed by the BOD "the re-election of Axel Hoos" was voted down at the AGM
with circa 20% of shareholders, with 1 Billion votes, voting against the motion.
It was done in a very public forum, the AGM.
The implication being that the BOD should not assume matters put to shareholders will attract automatic endorsement.
It means potentially a significant block of shareholders have exercised control in whom is appointed as Non Executive Director, against the express wishes of the BOD.
There are only a limited number of entities controlling sufficient numbers of shares to enable such an action to be executed without knowledge of the events amongst the broader church of shareholders.
One could also ponder the consequences of such an event if the matter being voted on was say a renumeration report or issuance of new shares for example?
It will be intriguing to see whom the new NED appointment may be, as well as what transpires with subsequent director re nominations?.
The speculation has been that a group of major shareholders didn't like the perceived conflict of interest with Axel being appointed CEO of scorpion?.
- Forums
- ASX - By Stock
- Ann: Results of Meeting Percentages
IMU
imugene limited
Add to My Watchlist
7.69%
!
1.4¢

It means a recommendation backed by the BOD "the re-election of...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $104.5M |
Open | High | Low | Value | Volume |
1.3¢ | 1.4¢ | 1.2¢ | $134.2K | 10.31M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 1168170 | 1.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.4¢ | 9464131 | 33 |
Last trade - 16.10pm 01/07/2025 (20 minute delay) ? |
Featured News
IMU (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online